Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
Crossref DOI link: https://doi.org/10.1007/s00262-014-1613-0
Published Online: 2014-09-28
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kimura, Hideki
Matsui, Yukiko
Ishikawa, Aki
Nakajima, Takahiro
Yoshino, Mitsuru
Sakairi, Yuichi
License valid from 2014-09-28